Fierce Pharma
JULY 22, 2024
As lawmakers and industry groups seek to get a handle on U.S. | As lawmakers and industry groups seek to get a handle on U.S. drug shortages, a new white paper from German market analytics firm QYOBO supports the thesis that disproportionately low prices for generic medicines can make it difficult for drugmakers to keep supplies afloat.
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 22, 2024
After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag. | Agilent has revealed that it’s signed a definitive agreement to acquire Biovectra for $925 million through a mix of cash and debt financing. The deal is expected to close this year.
MedCity News
JULY 22, 2024
Anthropic’s Claude3-Opus performed better than GPT-4, but both fell short of humans on a test of objective medical knowledge. The study was conducted by a firm developing LLMs specifically for healthcare that claim to be incorporating peer-reviewed sources of information. The post In This Round, Humans 1, AI LLMs 0 appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
JULY 22, 2024
At his vacation home in Delaware, President Joe Biden made the striking announcement that he is dropping out of the 2024 | While President Joe Biden is officially out for the 2024 election, his term has certainly made a mark in the healthcare realm.
MedCity News
JULY 22, 2024
Ionis Pharmaceuticals is looking ahead to a Phase 3 study for an antisense medicine it is developing to treat Angelman syndrome, a rare neurodevelopmental disorder with no FDA-approved therapies. Its main competition is an Ultragenyx Pharmaceutical drug set to begin pivotal testing later this year. The post Neuro Drug Passed Up by Biogen Posts Positive Data for Ionis, Setting Stage for Phase 3 Test appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JULY 22, 2024
For folks on the transplant waiting list, the wait from now on should be less disruptive. Life should be more pleasant. And all things being equal, one’s condition going into a transplant should be better. The post Home Dialysis Advances Will Make Transplant Wait a Little Easier appeared first on MedCity News.
Fierce Pharma
JULY 22, 2024
Grünenthal has continued its expansion splurge, | Grünenthal has continued its expansion splurge, acquiring Valinor Pharma and its lone commercial product Movantik (naloxegol), a treatment for opioid-induced constipation (OIC), for $250 million.
pharmaphorum
JULY 22, 2024
Scientists at OHSU in the US have developed a universal form of influenza vaccine that they say could protect against all strains of the virus
MedCity News
JULY 22, 2024
Pediatric mental health is the theme of the Pitch Perfect contest at the INVEST Digital Health conference at Pegasus Park in Dallas on September 18. Here’s a look at some of the pediatric mental health companies to watch. The post The Pediatric Innovation Landscape appeared first on MedCity News.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JULY 22, 2024
Consumer wearables have shown a benefit when used to monitor treatment responses in patients with atrial fibrillation and heart failure.
PharmaTimes
JULY 22, 2024
Cardiovascular disease, including coronary heart disease, currently affects around seven million people in the UK
pharmaphorum
JULY 22, 2024
Pain medicine specialist Grünenthal has agreed to buy Valinor Pharma for $250m, getting control of Movantik for opioid-induced constipation
MedCity News
JULY 22, 2024
In the realm of inclusivity and equity, planning early and engaging key stakeholders throughout the process makes it possible to make these changes while also safeguarding participants. How can researchers put clinical trial equity into practice? The post Implementing Inclusivity: Putting Clinical Trial Equity Into Practice appeared first on MedCity News.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
JULY 22, 2024
Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life-threatening mosquito-borne disease.
Pharmaceutical Commerce
JULY 22, 2024
The latest news for pharma industry insiders.
MedCity News
JULY 22, 2024
Vitable’s $16 million Series A funding round was led by Cherryrock Capital and included participation from newark venture partners, Citi Impact Fund, First Round Capital, Commerce Ventures and Y Combinator. In total, Vitable has raised more than $25 million. The post Vitable Secures $16M To Provide Primary Care to Small Employers appeared first on MedCity News.
Spotio
JULY 22, 2024
In both inside and outside sales environments, a lot of emphasis is placed on nurturing leads and closing deals. And while those steps are crucial when it comes to locking down new clients, improving your team’s activity-to-appointment ratio should also be a priority. The first step toward closing a deal is getting a prospect to commit to that first appointment, after all.
MedCity News
JULY 22, 2024
The advancement, adoption of, and access to these options – regardless of age, geography, and financial considerations – requires the support of the scientific community, drug developers, funders, regulatory agencies, insurers, and lawmakers to make the concept of a hormone-free future a reality. The post The Future of Birth Control: No Hormones, More Options for Men appeared first on MedCity News.
Pharmaceutical Technology
JULY 22, 2024
As the use of AI soared across healthcare, NVIDIA fit the bill in providing the necessary technology – and its stock tells the same story.
MedCity News
JULY 22, 2024
Discover the best practices in revenue cycle management to enhance financial health and streamline administrative processes in healthcare. The post Best Practices in Achieving Revenue Cycle Excellence appeared first on MedCity News.
Pharmaceutical Technology
JULY 22, 2024
The EMA has accepted for review GSK’s MAA for Blenrep for relapsed or refractory multiple myeloma (r/r MM).
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTimes
JULY 22, 2024
Primary sclerosing cholangitis is estimated to affect one in 100,000 people worldwide annually
pharmaphorum
JULY 22, 2024
Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and Eli Lilly.Mazdutide – a once-weekly injectable Innovent licensed from Lilly – was submitted to China's National Medical Products Administration (NMPA) earlier this year for weight management in overweight and obesity, and will soon be submitted for type 2 diabetes as well after a second positive phase 3 trial,
PharmaVoice
JULY 22, 2024
With great potential in cell and gene therapies, there are still plenty of barriers to getting the breakthroughs to patients.
Pharmacy Times
JULY 22, 2024
Eculizumab-aagh does not have an interchangeable designation, though that could be updated in the future.
Pharmaceutical Technology
JULY 22, 2024
UNAIDS executive director Winnie Byanyima called upon Gilead to allow generics to be made of lenacapavir now.
Pharmacy Times
JULY 22, 2024
Study investigators surveyed nearly 200 women on their concern around period-tracking apps’ data practices, as well as whether Roe v Wade being overturned influenced their concerns.
Cesare Ferrari
JULY 22, 2024
One of the challenges in medical sales is disseminating the right messages to the right doctors at the right time. Previously, I discussed how to identify the right customer and pass the right message ; today’s post will focus on when to pass the message, knowing fully well that timing is critical. This is equally because the degree of difficulty of the “targeting at right time” challenge is unique to each specific message, campaign and customer.
PharmaTech
JULY 22, 2024
An integrated platform that keeps real-time data in a single location can be a major asset for pharmaceutical companies, as it saves time and money, leading to better quality products and higher profits.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
321 
Let's personalize your content